Susac syndrome: Clinical characteristics and treatment in 29 new cases

European Journal of Neurology

Volumn 19, Issue 6, 2012, Pages 800-811

  Mateen, F J ^a,b   Zubkov, A Y ^c   Muralidharan, R ^a   Fugate, J E ^a   Rodriguez, F J ^b   Winters, J L ^a   Petty, G W ^a  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c Minneapolis Clinic of Neurology   (United States)

Author keywords

Cochlea; Encephalopathy; Plasma exchange; Retina; Stroke; Susac syndrome; Treatment; Vasculopathy; Young adults

Indexed keywords

ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CORPUS CALLOSUM; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SUSAC SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; CORPUS CALLOSUM; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLASMA EXCHANGE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SUSAC SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860918292     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03627.x     Document Type: Article

References (22)

1. Susac JO, Hardman JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology 1979; 29: 313-316.
2. Rennebohm R, Susac JO, Egan RA, Daroff RB. Susac's syndrome - update. J Neurol Sci 2010; 299: 86-91.
3. Petty GW, Engel AG, Younge BR, et al. Retinocochleocerebral vasculopathy. Medicine (Baltimore) 1998; 77: 12-40.
4. Petty GW, Matteson EL, Younge BR, et al. Recurrence of Susac syndrome (retinocochleocerebral vasculopathy) after remission of 18years. Mayo Clin Proc 2001; 76: 958-960.
5. Bogousslavsky J, Gaio JM, Caplan LR, et al. Encephalopathy, deafness and blindness in young women: a distinct retinocochleocerebral arteriolopathy? J Neurol Neurosurg Psychiatry 1989; 52: 43-46.
6. Vila N, Graus F, Blesa R, Santamaria J, Ribalta T, Tolosa E. Microangiopathy of the brain and retina (Susac's syndrome): two patients with atypical features. Neurology 1995; 45: 1225-1226.
7. Do TH, Fisch C, Evoy F. Susac syndrome: report of four cases and review of the literature. AJNR Am J Neuroradiol 2004; 25: 382-388.
8. Hahn JS, Lannin WC, Sarwal MM. Microangiopathy of brain, retina, and inner ear (Susac's syndrome) in an adolescent female presenting as acute disseminated encephalomyelitis. Pediatrics 2004; 114: 276-281.
9. Snyers B, Boschi A, De Potter P, et al. Susac syndrome in four male patients. Retina 2006; 26: 1049-1055.
10. Fox RJ, Costello F, Judkins AR, et al. Treatment of Susac syndrome with gamma globulin and corticosteroids. J Neurol Sci 2006; 251: 17-22.
11. Rennebohm RM, Susac JO. Treatment of Susac's Syndrome. J Neurol Sci 2007; 257: 215-220.
12. Maillart E, Deschamps R, Moulignier A, et al. [Susac syndrome: study of five cases]. Rev Neurol (Paris) 2009; 165: 575-582.
13. Saux A, Niango G, Charif M, et al. Susac's syndrome, a rare, potentially severe or lethal neurological disease. J Neurol Sci 2010; 297: 71-73.
14. Wildemann B, Schülin C, Storch-Hagenlocher B, et al. Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy. Stroke 1996; 27: 149-151.
15. Papo T, Biousse V, Lehoang P, et al. Susac syndrome. Medicine (Baltimore) 1998; 77: 3-11.
16. O'Halloran HS, Pearson PA, Lee WB, et al. Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature. Ophthalmology 1998; 105: 1038-1044.
17. Aubart-Cohen F, Kelin I, Alexandra JF, et al. Long-term outcome in Susac syndrome. Medicine (Baltimore) 2007; 86: 93-102.
18. Hardy TA, Garsia RJ, Halmagyi GM, et al. Tumor necrosis factor (TNF) inhibitor therapy in Susac's syndrome. J Neurol Sci 2011; 302: 126-128.
19. Rankin J. Cerebrovascular accidents in patients over the age of 60. I. General considerations. Scott Med J 1957; 2(4): 127-136.
20. Marie I, Maurey G, Herve F, et al. Intravenous immunoglobulin-associated arterial and venous thrombosis: report of a series and review of the literature. Br J Dermatol 2006; 155: 714-721.
21. Paran D, Herishanu Y, Elkayam O, et al. Venous and arterial thrombosis following administration of intravenous immunoglobulins. Blood Coagul Fibrinolysis 2005; 16: 313-318.
22. Linker RA, Gold R. Use of intravenous immunoglobulin and plasma exchange in neurological disease. Curr Opin Neurol 2008; 21: 358-365.